What does a vulnerable dependency mean for a surgical or hospital robot?

A vulnerable dependency in a surgical or hospital robot is a library inside the device's software that has a known flaw. Whether it matters depends on whether the flawed code is reachable, who can patch it and what clinical impact an update would have. The hospital usually cannot patch alone.

We are not describing any specific incident or product. This is a calm explanation of how the question works, with the standards and guidance we could confirm. It is not clinical or regulatory advice.

What is actually inside the robot?

Robots are made of firmware, an operating system, vision and motion software, network services and a stack of open source libraries. Each library has its own dependencies. A flaw can sit several layers down, in code the manufacturer never wrote and the hospital never sees.

NIST's guide to operational technology security describes OT as "a broad range of programmable systems and devices that interact with the physical environment." Its scope includes building automation, physical access control and other systems where software acts on the physical world. A hospital robot belongs to that family of systems, even though it is also a medical device with its own regulation.

Why is this not a normal patching problem?

In an office, you patch a laptop. With a robot:

• The manufacturer controls the software. Changing it yourself can void support, and may change a validated device in ways that matter for safety.
• Downtime is not free. A robot may be scheduled for procedures. A patch window needs coordination with clinical staff.
• An update is itself a risk. A change that fixes a security flaw can alter behavior. That needs the manufacturer's testing.
• Reachability is hard to judge from outside. Without the manufacturer's analysis, you cannot tell whether the flawed function is ever called.

What does regulation say?

The FDA's premarket cybersecurity guidance page says the guidance addresses the agency's recommendations on section 524B of the Federal Food, Drug, and Cosmetic Act for cyber devices, and the documentation it recommends in premarket submissions. We read only the summary page, so we will not describe the specific requirements. If you make or buy medical devices, read the full guidance.

On the industrial side, the ISA/IEC 62443 series splits responsibility across roles: asset owners, product suppliers, integrators and service suppliers. Part 4-1 addresses secure product development lifecycles, and Part 2-1 covers security program requirements for asset owners. The practical lesson: the manufacturer is responsible for building security in, and the hospital is responsible for operating the device safely and managing risk around it.

What can a hospital do?

You cannot read the manufacturer's code, but you can ask.

CISA describes a software bill of materials as "a list of ingredients that make up software components." It also describes VEX, a Vulnerability Exploitability eXchange, as an attestation that indicates whether products are affected by known vulnerabilities. Together they let a manufacturer say "this library is present" and "this flaw does not affect this product, because the code is not used." Ask for both.

Safeguard's CLI can scan an SBOM you receive from a supplier, in SPDX or CycloneDX form, and match it against its advisory database. That gives your team a first view of which components are known to be flawed. It does not tell you whether the flaw is exploitable in the robot, which is the manufacturer's call.

What compensating controls help?

When a patch is not available yet, reduce exposure around the device: segment its network, restrict who can reach it, limit remote access and monitor traffic to and from it. NIST's guide discusses security countermeasures for OT with performance, reliability and safety in mind. Choose controls that do not interfere with the device's safe operation, and confirm with the manufacturer.

What to do

1. Inventory every robot and connected surgical system, with manufacturer and software version.
2. Ask each manufacturer for an SBOM and for VEX statements.
3. Scan received SBOMs against known vulnerability data and list the flagged components.
4. Send the manufacturer the list and ask for an impact statement and a patch timeline.
5. Put compensating controls in place for flagged devices, and record them.
6. Agree a patch window process with clinical leaders in advance.
7. Add SBOM and vulnerability notification duties to the next purchase contract.
8. Review the list each quarter.

Quick check

Sources

• NIST SP 800-82 Rev. 3, Guide to Operational Technology Security
• ISA/IEC 62443 series of standards
• FDA: Cybersecurity in Medical Devices, premarket submissions guidance
• CISA: Software Bill of Materials
• Safeguard CLI documentation

Last reviewed: 18 October 2026.